Drug Actives from Bench into Market.
Home Über Girindus Leistungsspektrum Investor Relations Kontakt Sitemap
English
CAPABILITIES
Leistungsspektrum
Verfahrensentwicklung
Scale-Up
Produktion
Biotechnologie
Radiochemie
Medchem
Synthese Design
Qualität & Compliance
Regulatory Affairs
Oligonukleotide
Cosmetic Ingredients
Produkte

Radiolabeling  Capabilities

 


The radiochemistry facility of Girindus consists of four state of the art radiochemical synthesis cells dedicated and licensed for the use of select radioisotopes (14C, 3H, 125I, 35S, 32P). Our staff of radiochemists with extensive experience encompassing nuclear medicine, medicinal chemistry, radiochemistry and organic synthesis can advise and discuss your radiolableing needs.
 



The modern chemical synthesis facilities are available for synthesis optimization and radiochemical development to insure the cost effective synthesis of your radiolabeled API with the highest
quality.
Girindus will also work with your Quality group to deliver radiolabeled API’s prepared under cGMP conditions.

  • 1000 sq. ft. Laboratory Dedicated to Cold Development Chemistry

  • 4 Dedicated Modern Radiochemistry Cells Licensed for Carbon-14 and Tritium Use

  • Radiolabeling of Oligonucleotides

  • cGMP Radiosynthesis of API’s for ADME/Pharmacokinetics Available

  • Experienced in all phases of radiochemistry from synthesizing reactive intermediates to performing complex multistep radiosyntheses.


    • Please find detailed information on our radiolabeling capabilites in the attached PDF file:

    nach oben

                                                                                                                                                                                                                                                                                                                                                                                                   


    Development & Production Center
    Cincinnati, Ohio/USA